United Therapeutics (UTHR) Misses Q1 EPS by 117c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $584.93 -1.33%
EPS Growth %: -13.3%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: -13.3%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.82, $1.17 worse than the analyst estimate of $6.99. Revenue for the quarter came in at $781.5 million versus the consensus estimate of $798.85 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US offers Constellation Energy $5B loan for nuclear upgrades
- Innio NV (INIO) PT Lowered to $35 at BNP Paribas Exane
- Litchfield Hills Starts Vantage Corp. (VNTG) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
